Psychopharmaceuticals and Medicated Soldiering in America's post-9/11 Military
9/11 事件后美国军队中的精神药物和药物治疗
基本信息
- 批准号:1851014
- 负责人:
- 金额:$ 27.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-15 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The United States military has seen an unprecedented and marked turn to the use of psychiatric medications by service personnel in the post-9/11 wars in Iraq and Afghanistan. In 2006, the US Department of Defense developed for the first time official criteria for the use of FDA-approved psychiatric medications "in theater", in the physical and tactical spaces of military operations including active combat. Conservative estimates suggest that 1 in 6 service members is now taking at least one psychiatric medication. The use of psychiatric medications by the US military has attracted public attention, and is poised to influence the ways that Americans think about soldiering and the nature of war. Studies on the topic remain largely theoretical and center on the ethics of military psychiatric medication use. This project aims to understand how these medications are prescribed and used in practice, as well as how military service members understand medication effects on the work of counterinsurgency. The results from this study will have important implications for public knowledge and policy, as well as for veteran advocates and clinical practice aimed at the post-service transition of veterans. The project fosters the inclusion of underrepresented student veterans in military and veteran-related academic research and to support diversity in social and behavioral science. It will do so by 1) mentoring student veterans, 2) bringing together researchers and veterans in a symposium to address ways forward for collaborative research, and 3) publishing a co-edited volume on this important topic. Dr. Jocelyn Chua of the University of North Carolina at Chapel Hill will explore how psychiatric medications have been assimilated into the operations, infrastructures and norms of post-9/11 counterinsurgency, how these medications are understood and experienced by soldiers, and what impact these medications have had on the cultural landscape of soldiering in the U.S. Given the Army's prescription trends and prominent role in ground combat operations compared with other military branches, the research will focus on the US Army, Army Reserve, and Army National Guard. The PI and research team will use in-depth interviews, focus groups, and ethnographic observation to understand the formal and informal ways that psychiatric medications are being prescribed, accessed, used, and shared. The research team will also assess enlisted soldiers' experiences of psychiatric medication use in deployment and their evaluations of the propriety of these medications to counterinsurgency soldiering. The PI will also conduct archival research to contextualize current military psychiatric medication use within the recent history of the practice of US military behavioral and mental health. Research will be based in North Carolina and Washington, DC. Home to four military bases, including Fort Bragg Army base, North Carolina currently has the third highest number of active duty and reserve members of all US states. The National Archives and the National Library of Medicine in Washington, DC and Maryland, respectively, house extensive military resources for the archival research. Findings from this research will illuminate how psychiatric medications are used in deployment and soldiers' own accounts of their use in order to determine the extent to which theoretical concerns and public debate align with the experiences and concerns of soldiers themselves.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
在9·11事件后的伊拉克和阿富汗战争中,美国军方看到了服役人员使用精神药物的史无前例的显著转变。2006年,美国国防部首次制定了官方标准,用于在包括主动作战在内的军事行动的物理和战术空间中“在战区”使用FDA批准的精神药物。保守的估计表明,现在每6名服役人员中就有1人正在服用至少一种精神药物。美军使用精神药物引起了公众的关注,并有望影响美国人对当兵和战争性质的看法。关于这一主题的研究在很大程度上仍然是理论上的,并集中在军事精神药物使用的伦理问题上。该项目旨在了解这些药物在实践中是如何开出和使用的,以及军人如何了解药物对反叛乱工作的影响。这项研究的结果将对公众知识和政策以及退伍军人倡导者和旨在退伍军人服务后过渡的临床实践具有重要影响。该项目促进将未被充分代表的退伍军人学生纳入军队和退伍军人相关的学术研究,并支持社会和行为科学的多样性。它将通过以下方式做到这一点:1)指导退伍军人学生;2)将研究人员和退伍军人聚集在一起,讨论合作研究的前进方向;3)出版一本关于这一重要主题的共同编辑的卷。北卡罗来纳大学教堂山分校的Jocelyn Chua博士将探索精神药物如何被吸收到9/11后反叛乱的行动、基础设施和规范中,士兵如何理解和体验这些药物,以及这些药物对美国士兵的文化格局产生了什么影响。考虑到陆军的处方趋势和与其他军事部门相比在地面作战中的突出作用,这项研究将集中在美国陆军、陆军预备役和陆军国民警卫队。PI和研究团队将使用深入访谈、焦点小组和人种学观察,以了解精神药物的正式和非正式方式被开出、获取、使用和分享。研究小组还将评估应征士兵在部署中使用精神药物的经验,以及他们对这些药物对反叛乱士兵的适当性的评价。PI还将进行档案研究,将当前军事精神药物的使用与美国军事行为和精神健康实践的近期历史联系起来。研究将设在北卡罗来纳州和华盛顿特区。北卡罗来纳州拥有包括布拉格堡陆军基地在内的四个军事基地,目前拥有美国各州第三多的现役和预备役人员。分别位于华盛顿特区和马里兰州的国家档案馆和国家医学图书馆为档案研究提供了大量的军事资源。这项研究的结果将阐明精神科药物在部署中是如何使用的,以及士兵自己对其使用的描述,以确定理论上的关切和公众辩论在多大程度上符合士兵本身的经历和关切。这一奖项反映了NSF的法定使命,并通过使用基金会的智力价值和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Escaping the Clinic: Exposure as Care among Military Medical Professionals at War
逃离诊所:战时军事医疗专业人员的暴露护理
- DOI:10.17157/mat.9.2.5250
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Chua, Jocelyn Lim
- 通讯作者:Chua, Jocelyn Lim
Medication by Proxy: The Devolution of Psychiatric Power and Shared Accountability to Psychopharmaceutical Use Among Soldiers in America’s Post-9/11 Wars
代理用药:9/11 战争后美国士兵精神科权力的下放和精神药物使用的共同责任
- DOI:10.1007/s11013-020-09673-7
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Chua, Jocelyn Lim
- 通讯作者:Chua, Jocelyn Lim
Buddy Watch: Care and Constraint Under the Watchful Eye of Military Suicide Risk Management in War
好友观察:战争中军事自杀风险管理的关怀与约束
- DOI:10.1111/etho.12281
- 发表时间:2020
- 期刊:
- 影响因子:0.6
- 作者:Lim Chua, Jocelyn
- 通讯作者:Lim Chua, Jocelyn
Pharmaceutical Creep: U.S. Military Power and the Global and Transnational Mobility of Psychopharmaceuticals
制药业的蔓延:美国军事力量与精神药物的全球和跨国流动
- DOI:10.1111/maq.12520
- 发表时间:2020
- 期刊:
- 影响因子:2.2
- 作者:Lim Chua, Jocelyn
- 通讯作者:Lim Chua, Jocelyn
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jocelyn Chua其他文献
Jocelyn Chua的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jocelyn Chua', 18)}}的其他基金
Doctoral Dissertation Research: Psychiatric Deinstitutionalization and Community Mental Health Transitions
博士论文研究:精神病去机构化和社区心理健康转变
- 批准号:
2116127 - 财政年份:2021
- 资助金额:
$ 27.5万 - 项目类别:
Standard Grant
Doctoral Dissertation Research: Security and Preparedness in U.S. Public Schools
博士论文研究:美国公立学校的安全和准备
- 批准号:
2016997 - 财政年份:2020
- 资助金额:
$ 27.5万 - 项目类别:
Standard Grant
相似海外基金
ENVIROMENTAL ASSESSMENT for SLICE® (emamectin benzoate) Type A Medicated Article for Freshwater-Reared Salmonids
针对淡水养殖鲑鱼的 SLICE®(甲维盐)A 型药物制品的环境评估
- 批准号:
10770820 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别:
SBIR Phase I: Development of a nasal compression device with medicated intranasal sponges for the treatment of nosebleeds in any setting
SBIR 第一阶段:开发带有含药鼻内海绵的鼻压缩装置,用于治疗任何情况下的流鼻血
- 批准号:
2136297 - 财政年份:2022
- 资助金额:
$ 27.5万 - 项目类别:
Standard Grant
The Safety of AQUAFLOR (50% florfenicol; Type A Medicated Article) Administered in Feed to Marine Finfish Species
%20Safety%20of%20AQUAFLOR%20(50%%20氟苯尼考;%20Type%20A%20Medicated%20Article)%20Administered%20in%20Feed%20to%20Marine%20Finfish%20Species
- 批准号:
10562359 - 财政年份:2022
- 资助金额:
$ 27.5万 - 项目类别:
Platelet-medicated deregulation of dendritic cell function- implications for anti-HIV immune responses and immunotherapy
血小板药物对树突状细胞功能的失调——对抗 HIV 免疫反应和免疫治疗的影响
- 批准号:
10402968 - 财政年份:2021
- 资助金额:
$ 27.5万 - 项目类别:
Platelet-medicated deregulation of dendritic cell function- implications for anti-HIV immune responses and immunotherapy
血小板药物对树突状细胞功能的失调——对抗 HIV 免疫反应和免疫治疗的影响
- 批准号:
10516746 - 财政年份:2021
- 资助金额:
$ 27.5万 - 项目类别:
A novel medicated surgical hydrogel to prevent epidural adhesions post-laminectomy
一种新型药物手术水凝胶,用于预防椎板切除术后硬膜外粘连
- 批准号:
nhmrc : GNT1153663 - 财政年份:2019
- 资助金额:
$ 27.5万 - 项目类别:
Development Grants
Targeted Drug Delivery to the Cornea of the Eye Via Medicated Contact Lenses and Mucoadhesive Thin Films
通过药用隐形眼镜和粘膜粘附薄膜将靶向药物递送至眼角膜
- 批准号:
BB/S004874/1 - 财政年份:2019
- 资助金额:
$ 27.5万 - 项目类别:
Research Grant
Hormone-medicated improvement of recombinant protein yields in plants
激素药物提高植物重组蛋白产量
- 批准号:
495852-2016 - 财政年份:2018
- 资助金额:
$ 27.5万 - 项目类别:
Collaborative Research and Development Grants
Possible acquired long QT syndrome in infant induced by medicated mother
药物母亲可能诱发婴儿获得性长QT综合征
- 批准号:
18K07552 - 财政年份:2018
- 资助金额:
$ 27.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Hormone-medicated improvement of recombinant protein yields in plants
激素药物提高植物重组蛋白产量
- 批准号:
495852-2016 - 财政年份:2017
- 资助金额:
$ 27.5万 - 项目类别:
Collaborative Research and Development Grants